GHK-Cu: What the Copper Tripeptide Research Literature Covers
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a sequence first described as a fragment present in human plasma that binds copper with high affinity.
Published work is largely in-vitro and includes fibroblast culture studies, extracellular matrix protein expression, and broad gene-expression profiling experiments; conclusions about human cosmetic or clinical outcomes are not established by that work.
Because the molecule is a metal complex, copper stoichiometry and solution chemistry are handling variables that do not apply to ordinary peptides. None of the compounds described here is an approved drug for the uses discussed, and nothing on this page should be read as evidence of safety or effectiveness in humans. All products referenced on this site are supplied for in-vitro laboratory research use only. They are not drugs, foods, cosmetics or medical devices, and they are not for human or veterinary consumption or administration.
The molecule and why the copper matters
Glycyl-L-histidyl-L-lysine is a tripeptide first reported as a copper-binding component of human plasma. The histidine imidazole nitrogen together with the terminal amine and the peptide backbone provide a coordination environment that binds copper(II) tightly, which is what turns a short and otherwise unremarkable sequence into a defined metal complex with its own chemistry.
That chemistry has practical consequences. The complex is colored, its solution behavior depends on pH, and free copper released from the complex is itself redox active in an assay. A vehicle control for GHK-Cu work therefore has to consider copper as well as the peptide, which is not true of the unmetallated peptides in the same catalog.
Applied to specific lots, this is what you will see on the documentation for GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper(II) Complex) 100MG, GLOW Blend (BPC-157 / TB-500 / GHK-Cu) 70MG and KLOW Blend (GHK-Cu + KPV + BPC-157 + TB-500) 80MG.
What the published work examines
Most cited studies are cell culture experiments in dermal fibroblasts and keratinocytes, with readouts covering collagen and other extracellular matrix protein expression, metalloproteinase and antiprotease balance, and broad gene-expression profiling that reports directional changes across large gene sets. A parallel literature treats the tripeptide as a copper transport species and studies copper homeostasis rather than the peptide itself.
Gene-expression breadth is easy to over-read. A profiling study reporting changes across many transcripts describes an observed response in a specific cell type under specific culture conditions. It does not establish that any downstream tissue-level or appearance-level outcome follows, and the literature does not support that step.
The Lab Notes that work through this in more detail are GHK-Cu Copper Peptide: 2026 Research Literature Roundup and Peptide Reconstitution Basics.
Handling and documentation
As supplied for research the material is lyophilized and handled like other lyophilized peptides: equilibrated before opening, reconstituted without vigorous agitation, aliquoted to avoid repeated freeze and thaw, stored dry and cold, and calculated from net peptide content. Light exposure and pH excursions are worth recording specifically because of the metal center.
Documentation should tie the lot number, the certificate of analysis with its stated chromatographic method, the copper content figure where reported, the diluent and its lot, and the calculated concentration together. All products referenced on this site are supplied for in-vitro laboratory research use only. They are not drugs, foods, cosmetics or medical devices, and they are not for human or veterinary consumption or administration.
Common questions
What is GHK-Cu?
GHK-Cu is a copper-binding tripeptide complex: the amino acid sequence glycine-histidine-lysine coordinated to a copper(II) ion. The free tripeptide GHK was originally identified in human plasma, and its histidine imidazole and adjacent amine groups give it a high affinity for copper. In research it is handled as a metal-peptide complex rather than as a simple peptide, since copper coordination governs its color, solubility behavior and stability in solution.
What has GHK-Cu been studied for?
The literature is dominated by in-vitro work in dermal fibroblast and keratinocyte culture, examining extracellular matrix protein expression including collagen and glycosaminoglycans, along with broad transcriptional profiling experiments that report changes across large sets of genes. There is also a body of work on copper homeostasis and on the tripeptide's behavior as a copper carrier. These are cell-level and gene-expression observations; they are not demonstrations of a cosmetic or clinical result in people.
Does the copper change how a GHK-Cu lot is verified?
It adds a measurement. Purity and identity are still established chromatographically and by mass spectrometry, but a complete record for a metal complex also accounts for copper content and for the fact that the coordinated and uncoordinated species behave differently in a chromatographic system. Stated method conditions matter even more here than for an unmetallated peptide, because coordination chemistry is sensitive to the acidic modifier used in a reverse-phase gradient.
Sources
Primary standards, regulatory guidance and reference data. Links open in a new tab.
- PubMed — GHK-Cu copper tripeptide literatureNational Library of Medicine
- PubChem — glycyl-L-histidyl-L-lysine compound recordNational Center for Biotechnology Information
- USP General Chapters (packaging, storage and water determination)United States Pharmacopeia
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.